Medtronic StealthStation Accelerates Precision Adoption
Precision Neuroscience
This partnership matters because it lets Precision ride an existing neurosurgery buying system instead of teaching every hospital to buy a new standalone BCI tool from scratch. StealthStation is already used in surgical navigation, so integrating Layer 7 can make Precision look less like a research device and more like one more module in an operating room setup that surgeons, procurement teams, and Medtronic reps already know how to evaluate and support.
-
Medtronic sells a connected neurosurgery stack, including navigation, imaging, and robotics, and has said AiBLE has more than 10,000 installations worldwide. That gives Precision a much larger hospital entry point than a startup field team could build on its own, especially outside the U.S.
-
The practical sales motion is simple. A hospital already using StealthStation for cranial workflows can evaluate Layer 7 inside a familiar software and hardware environment, with Medtronic reps helping position it alongside existing capital equipment rather than as an orphan device needing a separate champion.
-
This is especially important in BCI, where peers like Synchron and Neuralink still face long clinical and reimbursement ramps for permanent implants. Precision can first monetize temporary mapping cases, then use Medtronic distribution to turn those cases into routine neurosurgical workflow before the full implant business arrives.
The next step is for Precision to become embedded in the standard neurosurgery toolchain, not just added onto it. If Layer 7 becomes a default option inside navigation guided cranial procedures, Precision enters the permanent BCI launch with surgeon familiarity, hospital accounts, and a commercial path that is already partly built.